Iridex (IRIX) Q4 2025 earnings review
Turnaround Achieved, But Margins and Geopolitics Cap Forward Growth
Iridex capped off a pivotal turnaround year with accelerating Q4 revenue (+16% YoY) and its first full year of positive Adjusted EBITDA ($1.1M) in recent history. The company successfully executed its aggressive cost-reduction mandate, slashing full-year operating expenses by 22%. However, the top-line beat masks severe gross margin compression—margins reversed from 44% a year ago to 37% this quarter due to tariff impacts and manufacturing inefficiencies. Looking to FY26, management is completely writing off the Middle East market due to geopolitical disruptions, leading to a tepid revenue guidance of $51-53M. The company has stopped the cash burn, but generating high-margin growth remains a challenge.
🐂 Bull Case
The company proved it can grow the top line (+16% in Q4) with a leaner organization. Operating expenses dropped 10% YoY in Q4, cementing the transition to a sustainable, positive Adjusted EBITDA profile.
Cyclo G6 probe sales hit 15,900 units in Q4 (up from 13,300 YoY). This recurring, high-margin disposable revenue base is expanding, validating the commercial strategy to focus on existing system utilization.
🐻 Bear Case
Despite a 16% jump in revenue, Q4 gross profit actually declined YoY ($5.47M vs $5.58M). Tariffs and higher manufacturing costs are eating into the bottom line, dropping margins by 700 basis points.
The Middle East conflict is directly hurting the top line. Management's guidance models zero sales in the region for 2026, stalling overall company growth to essentially flat on a reported basis.
⚖️ Verdict: ⚪
Neutral. The survival phase of the turnaround is a success—cash burn has stopped and EBITDA is positive. However, collapsing gross margins and international market disruptions prevent a more bullish outlook.
Key Themes
Gross Margin Squeeze Contradicts Profitability Narrative
While management touted a 'transformational year' for profitability, gross margin performance is deeply concerning. Margins decelerated to 37% in Q4, down from 44% in the prior year quarter. The absolute gross profit dollars shrank despite a $2 million increase in sales. This was driven by a confluence of rising manufacturing costs, tariff impacts throughout the year, and lower capitalization of overhead as inventory declined.
Macro Headwinds: Middle East Market Evaporation
A major macro risk materialized as management explicitly zeroed out the Middle East region from its 2026 revenue forecast. The ongoing conflict is severely impacting product delivery timelines. This single geographic disruption is suppressing overall company growth from a healthy trajectory to a stable but uninspiring 1% to 5% pro-forma growth rate.
Retina Segment Reversing Course
After facing sluggish capital equipment environments globally earlier in the year, the Retina business staged a massive comeback. Q4 retina product revenue accelerated to $8.9M, representing 22% YoY growth. This was fueled primarily by a resurgence in Pascal laser system sales.
Cyclo G6 Probe Utilization Steady
The strategic pivot away from merely placing G6 consoles toward driving procedural utilization of disposables is paying off. Q4 saw 15,900 Cyclo G6 probes sold, a healthy increase from 13,300 in the prior year. This stable, recurring revenue stream insulates the company somewhat from capital equipment spending cycles.
Relentless Operating Expense Discipline
The primary engine of the company's EBITDA turnaround remains its aggressive cost structure optimization. Operating expenses in Q4 were reduced by 10% YoY, bringing the full-year reduction to a staggering 22% ($21.8M down from $27.8M). This discipline allowed the company to generate positive EBITDA despite the gross margin collapse.
Manufacturing Transition Costs Lingering
The company's strategic shift to 3rd party contract manufacturers continues to drag on results. Following a $0.8M inventory write-down in Q3, Q4 margins were again pressured by 'lower capitalization of manufacturing overhead as inventory levels declined.' The transition costs are muddying the underlying unit economics of the hardware.
Other KPIs
Reversing a persistent trend of cash burn. Improved by $5.4 million from a $4.3 million loss in FY24. This marks a successful execution of the board mandate given to CEO Patrick Mercer to stabilize the core business.
Stable. The company actually generated $0.4 million in cash during Q4, ending the year with $6.0 million. While the absolute cash buffer is small, the transition to positive operating cash flow significantly de-risks the balance sheet.
Guidance
Stable to slightly Decelerating. The midpoint ($52M) implies a slight contraction from FY25's $52.7M. However, adjusting for the intentional exclusion of the Middle East market, the pro-forma expectation represents 1% to 5% growth.
Accelerating savings. Represents an additional step-down in costs, ensuring that even with flat revenue, the company can maintain positive operating margins.
Management expects to generate positive operating cash flow for the full year 2026, confirming that the Q4 milestone was not a one-off working capital maneuver.
Key Questions
Middle East Revenue Baseline
With the Middle East zeroed out for 2026, what was the exact revenue contribution of this region in 2025? Understanding this baseline is critical to evaluating the health of the remaining global business.
Gross Margin Floor
Gross margins collapsed 700 basis points in Q4 despite record revenues. How much of this is structural (permanent tariffs) versus transient (inventory drawdowns and contract manufacturing transitions)? What is the target steady-state gross margin?
Tariff Mitigation Updates
Given that management previously noted products were overwhelmingly sourced/manufactured in the U.S. to avoid tariffs, why did 'tariff developments' materially impact Q4 product costs, and what is the mitigation strategy for 2026?